Search

TransMedics Group Inc

Geschlossen

BrancheGesundheitswesen

83.46 4.08

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

81.2

Max

83.88

Schlüsselkennzahlen

By Trading Economics

Einkommen

-98M

7.3M

Verkäufe

13M

174M

KGV

Branchendurchschnitt

18.661

68.51

EPS

0.3

Gewinnspanne

4.206

Angestellte

898

EBITDA

-4.9M

28M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+12.31% upside

Dividenden

By Acuity

Nächstes Ergebnis

28. Okt. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-535M

2.8B

Vorheriger Eröffnungskurs

79.38

Vorheriger Schlusskurs

83.46

Nachrichtenstimmung

By Acuity

58%

42%

259 / 340 Ranking in Healthcare

TransMedics Group Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Aug. 2026, 19:22 UTC

News

TransMedics shares are higher as Piper Sandler and Needham adjust price targets, reflecting positive sentiment from multiple analysts during Friday's trading session.

6. Aug. 2026, 20:03 UTC

Social Media
News

Transmedics Group Inc shares are higher, supported by positive Q2 results and mentions in a fund manager's portfolio, despite potential short-term volatility concerns.

5. Aug. 2026, 20:03 UTC

Social Media
News

TransMedics Group Inc. shares are lower following mixed quarterly results and an earnings miss, prompting price target cuts from Piper Sandler and UBS.

4. Aug. 2026, 23:02 UTC

News
Social Media

Transmedics Group shares are lower in after-market hours following Q2 results, where adjusted EPS of $0.44 missed expectations despite revenue surpassing estimates.

3. Aug. 2026, 19:51 UTC

Social Media
News

TransMedics Group Inc. shares are rising, despite an analyst downgrade to a $106 price target from $142, amid positive social media discussions.

30. Juli 2026, 19:03 UTC

Transmedics Group Inc shares are lower during Thursday's session, with no specific news identified. Broader market uncertainty may be influencing the decline.

29. Juli 2026, 23:36 UTC

Transmedics Group Inc. shares are lower in after-market trading, reflecting broader market volatility amid rising interest rates and geopolitical tensions.

28. Juli 2026, 19:46 UTC

Transmedics Group Inc shares are higher today, advancing since Monday. The stock peaked earlier but pulled back from a session high.

27. Juli 2026, 15:16 UTC

Social Media
News

Transmedics Group Inc is higher today amid social media discussions on its undervaluation and expectations for significant profit by 2028.

24. Juli 2026, 20:02 UTC

Social Media

Transmedics Group Inc gains amid positive feedback from Jefferies on its technology and growth prospects, aligning with strength in the Health Care Equipment sector.

22. Juli 2026, 19:46 UTC

Transmedics Group Inc shares are lower today, reflecting ongoing declines. The stock's volatility coincides with rising crude oil prices amid geopolitical tensions.

21. Juli 2026, 14:36 UTC

Social Media

Transmedics Group's shares are higher today following the first lung transplant using its OCS warm-perfusion device, enhancing organ preservation and clinical outcomes.

20. Juli 2026, 12:26 UTC

Social Media

TransMedics Group Inc shares are higher in pre-market trading amid strong operational growth, with flights exceeding 36 per day and projected revenue of $3 billion by 2032.

Peer-Vergleich

Kursveränderung

TransMedics Group Inc Prognose

Kursziel

By TipRanks

12.31% Vorteil

12-Monats-Prognose

Durchschnitt 94.22 USD  12.31%

Hoch 122 USD

Tief 65 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für TransMedics Group Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

10 ratings

7

Buy

3

Halten

0

Sell

Stimmung

By Acuity

259 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
help-icon Live chat